DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 168 filers reported holding DIPLOMAT PHARMACY INC in Q2 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $262,000 | +31.0% | 10,240 | +3.0% | 0.02% | +20.0% |
| Q1 2018 | $200,000 | -14.5% | 9,945 | -14.8% | 0.02% | -16.7% |
| Q4 2017 | $234,000 | -5.3% | 11,675 | -2.1% | 0.02% | -10.0% |
| Q3 2017 | $247,000 | +19.9% | 11,927 | -14.3% | 0.02% | +5.3% |
| Q2 2017 | $206,000 | +2.0% | 13,924 | +9.9% | 0.02% | -5.0% |
| Q1 2017 | $202,000 | +2.5% | 12,674 | -19.1% | 0.02% | -9.1% |
| Q4 2016 | $197,000 | -62.5% | 15,665 | -16.5% | 0.02% | -64.5% |
| Q3 2016 | $525,000 | -19.8% | 18,761 | +0.3% | 0.06% | -27.1% |
| Q2 2016 | $655,000 | +14.9% | 18,706 | -10.2% | 0.08% | +9.0% |
| Q1 2016 | $570,000 | -55.6% | 20,821 | -44.5% | 0.08% | -56.7% |
| Q4 2015 | $1,283,000 | +58.2% | 37,501 | +32.9% | 0.18% | +40.6% |
| Q3 2015 | $811,000 | -31.9% | 28,224 | +6.1% | 0.13% | -22.0% |
| Q2 2015 | $1,191,000 | – | 26,605 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |